Sotera Health (NASDAQ:SHC) Hits New 52-Week Low – What’s Next?

Shares of Sotera Health (NASDAQ:SHC) hit a new 52-week low during trading on Thursday . The company traded as low as $10.71 and last traded at $10.73, with a volume of 609040 shares trading hands. The stock had previously closed at $11.50.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on SHC shares. The Goldman Sachs Group began coverage on shares of Sotera Health in a research note on Friday, December 6th. They issued a “neutral” rating and a $14.00 price objective for the company. Barclays reduced their price target on Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research report on Friday, February 28th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $16.00.

Sotera Health Stock Down 3.6 %

The stock’s fifty day moving average is $12.61 and its two-hundred day moving average is $13.82. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The firm has a market cap of $2.93 billion, a P/E ratio of 41.36 and a beta of 1.88.

Institutional Investors Weigh In On Sotera Health

A number of institutional investors and hedge funds have recently made changes to their positions in SHC. Blue Trust Inc. increased its stake in Sotera Health by 164.3% in the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after acquiring an additional 1,140 shares during the last quarter. Quarry LP bought a new stake in shares of Sotera Health during the 4th quarter valued at about $28,000. GAMMA Investing LLC grew its holdings in shares of Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after purchasing an additional 1,121 shares in the last quarter. Tower Research Capital LLC TRC increased its position in shares of Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock worth $82,000 after purchasing an additional 1,640 shares during the last quarter. Finally, Sterling Capital Management LLC raised its stake in Sotera Health by 58.5% in the fourth quarter. Sterling Capital Management LLC now owns 9,029 shares of the company’s stock valued at $124,000 after purchasing an additional 3,331 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.